{{Rsnum
|rsid=1439523
|Gene=PLD5
|Chromosome=1
|position=242368352
|Orientation=minus
|GMAF=0.1244
|Gene_s=PLD5
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 3.6 | 96.4
| HCB | 0.7 | 9.5 | 89.8
| JPT | 0.0 | 15.0 | 85.0
| YRI | 10.2 | 49.7 | 40.1
| ASW | 5.3 | 36.8 | 57.9
| CHB | 0.7 | 9.5 | 89.8
| CHD | 2.8 | 24.8 | 72.5
| GIH | 0.0 | 11.9 | 88.1
| LWK | 19.1 | 63.6 | 17.3
| MEX | 0.0 | 12.1 | 87.9
| MKK | 17.9 | 47.4 | 34.6
| TSI | 1.0 | 2.9 | 96.1
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23382691
  |Trait=IgG glycosylation
  |Title=Loci associated with N-glycosylation of human immunoglobulin G show pleiotropy with autoimmune diseases and haematological cancers.
  |RiskAllele=C
  |Pval=4E-6
  |OR=.61
  |ORtxt=[0.35-0.87] unit increase
  |OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}